Brain norepinephrine: Enhanced turnover after rubidium treatment
Jon M. Stolk 1,
William J. Nowack 1,
Jack D. Barchas 1, and
Stanley R. Platman 2
1 Department of Psychiatry, Stanford University School of Medicine, Stanford, California 94305
2 Department of Psychiatry, Downstate Medical School, State University of New York, Brooklyn
In the report "Brain norepinephrine: Enhanced turnover after rubidium treatment" by J. M. Stolk et al. (24 April, p. 501), the second sentence of paragraph 1, column 1, page 501, should read "The effectiveness of another alkali ion, lithium, in the treatment...."